Sagimet Biosciences Inc.
SGMT
$5.14
-$0.07-1.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -25.21% | -23.47% | -24.62% | -25.37% | 59.38% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 163.81% | -46.78% | 301.61% | -9.29% | -21.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.89% | 22.85% | 510.00% | 722.22% | 16.62% |
| Total Current Assets | -23.81% | -23.99% | -23.72% | -24.90% | 58.08% |
|
|
|||||
| Total Current Assets | -23.81% | -23.99% | -23.72% | -24.90% | 58.08% |
| Net Property, Plant & Equipment | 1.30% | 0.88% | 0.66% | 2.70% | 5.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -27.32% | -26.53% | -27.31% | -24.86% | 65.70% |
|
|
|||||
| Total Accounts Payable | -8.14% | 268.32% | -3.66% | 506.97% | 666.13% |
| Total Accrued Expenses | 25.15% | 69.93% | 44.86% | -2.48% | -39.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | -0.86% | -0.65% | 50.00% | 20.00% |
| Total Finance Division Other Current Liabilities | 440.00% | -27.27% | -90.00% | -- | -99.10% |
| Total Other Current Liabilities | 440.00% | -27.27% | -90.00% | -- | -99.10% |
| Total Current Liabilities | 14.53% | 123.51% | 26.52% | 59.20% | -21.22% |
|
|
|||||
| Total Current Liabilities | 14.53% | 123.51% | 26.52% | 59.20% | -21.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.53% | 123.51% | 26.52% | 59.20% | -21.22% |
|
|
|||||
| Common Stock & APIC | 1.49% | 1.46% | 1.37% | 1.34% | 32.31% |
| Retained Earnings | -17.28% | -20.66% | -22.45% | -22.28% | -18.25% |
| Treasury Stock & Other | -47.83% | -73.47% | 430.43% | 1,628.57% | 666.67% |
| Total Common Equity | -28.51% | -30.13% | -28.99% | -26.85% | 71.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -28.51% | -30.13% | -28.99% | -26.85% | 71.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -28.51% | -30.13% | -28.99% | -26.85% | 71.09% |
|
|
|||||